pembrolizumab
merck
['melanoma']
#esmo22 never thought that i would see near 80% event-free survival in melanoma during my professional lifetime. neoadjuvant io wins indeed!!! #s1801 
Translational Medical Oncologist (Biomarkers, Toxicities, Health Outcomes, Clinico-Genomic Big Data) @OncoAlert. Motto: "Let's make a difference". Views mine.